The FDA has approved a biologic bone graft for use in the cervical spine. The i-Factor peptide enhanced bone graft from Cerapedics Inc. (Westminster, Colo.), a private orthobiologics company, was approved as a drug-device combination product for use in anterior cervical disectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. The product represents the first FDA-approved bone graft in the cervical spine and the second FDA-approved bone graft in the spine. Read More
